PERSEUS-SOROS BIOPHARMACEUTICAL FUND
Perseus-Soros Biopharmaceutical Fund, L.P. specializes in equity investments in private and public life science companies.
PERSEUS-SOROS BIOPHARMACEUTICAL FUND
Status:
Active
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2009-10-30 | Xanodyne | Perseus-Soros Biopharmaceutical Fund investment in Venture Round - Xanodyne | 87.78 M USD |
| 2008-09-29 | CeNeRx BioPharma | Perseus-Soros Biopharmaceutical Fund investment in Series B - CeNeRx BioPharma | 15 M USD |
| 2007-11-14 | Ambit Biosciences | Perseus-Soros Biopharmaceutical Fund investment in Series D - Ambit Biosciences | 49.3 M USD |
| 2006-05-01 | Cardiokine | Perseus-Soros Biopharmaceutical Fund investment in Series B - Cardiokine | 50 M USD |
| 2006-04-12 | SkinMedica | Perseus-Soros Biopharmaceutical Fund investment in Series E - SkinMedica | 11 M USD |
| 2005-11-14 | CeNeRx BioPharma | Perseus-Soros Biopharmaceutical Fund investment in Series A - CeNeRx BioPharma | 8 M USD |
| 2005-05-12 | Ambit Biosciences | Perseus-Soros Biopharmaceutical Fund investment in Series C - Ambit Biosciences | 31 M USD |
| 2005-04-06 | SkinMedica | Perseus-Soros Biopharmaceutical Fund investment in Series E - SkinMedica | 15 M USD |
| 2005-03-02 | ArgiNOx Phamaceuticals | Perseus-Soros Biopharmaceutical Fund investment in Series C - ArgiNOx Phamaceuticals | 25 M USD |
| 2004-08-05 | Avera Pharmaceutical | Perseus-Soros Biopharmaceutical Fund investment in Series C - Avera Pharmaceutical | 48 M USD |
More informations about "Perseus-Soros Biopharmaceutical Fund"
Perseus-Soros Biopharmaceutical Fund - Crunchbase
Perseus-Soros Biopharmaceutical Fund has raised a total of $449M in a single venture fund, Perseus-Soros BioPharmaceutical Fund. This fund was announced on Jan 1, 2000 and raised …See details»
Perseus-Soros Biopharmaceutical Fund - Crunchbase
Perseus-Soros Biopharmaceutical Fund has made 4 diversity investments. Their most recent diversity investment was on Oct 30, 2009 , when Xanodyne raised obfuscatedSee details»
- Partnering For Cures
Supported by industry and the Bill & Melinda Gates Foundation, BVGH promoted financial incentives for tropical disease R&D and forged collaborations between leading companies and …See details»
Perseus-Soros Biopharmaceutical Fund — 22 Investments, …
Considering the real fund results, this VC is 3 percentage points less often commits exit comparing to other organizations. This Perseus-Soros Biopharmaceutical Fund works on 10 …See details»
Steven Elms – Oculex Pharmaceuticals Inc - The Wall Street …
Mar 17, 2003 STEVEN A. ELMS, Chairman of Oculex Pharmaceuticals, Inc., is a Managing Director of the Perseus-Soros BioPharmaceutical Fund. For five years prior to joining Perseus …See details»
Elms, Steven A. - The Wall Street Transcript
Mar 17, 2003 STEVEN A. ELMS, Chairman of Oculex Pharmaceuticals, Inc., is a Managing Director of the Perseus-Soros BioPharmaceutical Fund. For five years prior to joining Perseus …See details»
Perseus-Soros Biopharmaceutical Fund
Perseus-Soros Biopharmaceutical Fund Investments, Sectors and Contact Details. Perseus-Soros Biopharmaceutical Fund. Perseus-Soros Biopharmaceutical Fund, L.P. specializes in …See details»
Perseus Soros Biopharmaceutical Fund, L.P. | MyCapital
Perseus Soros Biopharmaceutical Fund, L.P., a leading venture capital and private equity company. See full company profile and detailed contact information. Email the partner directly …See details»
Biotechnology Investment Issues: Dennis Purcell - Perseus-soros ...
May 8, 2002 DENNIS J. PURCELL has been the Senior Managing Director of Perseus-Soros BioPharmaceutical Fund, LP (PSBF), since February 2000. He is responsible for the overall …See details»
New President and CEO of Bio Ventures for Global Health
BIO Ventures for Global Health (BVGH) has announced that Christopher D. Earl, PhD, a leading venture capitalist and entrepreneur in the biotechnology industry, has been appointed …See details»
Perseus-Soros Biopharmaceutical Fund - Updates, News
Perseus-Soros Biopharmaceutical Fund, L.P. specializes in equity investments in private and public life science companies.See details»
Philip Deutch - Board Member at Voltus - The Org
From 1997 to 2004, Mr. Deutch was Managing Director at Perseus, L.L.C., where he led or co-led the firm’s energy investing activities and was a member of the firm’s Executive Committee. At …See details»
CeNeRx raises $13M as it preps for Phase II | Fierce Biotech
Aug 13, 2010 Perseus Soros Biopharmaceutical Fund, L Capital Partners and Pappas Research Triangle Park-based CeNeRx BioPharma has raised $13 million to conduct Phase II trials of its …See details»
Tony Sun, M.D. - Immusoft
Tony Sun, a biotechnology industry consultant, has been involved in numerous life science company activities from company formation to fundraising to capital market exits to …See details»
Purcell, Dennis J. - The Wall Street Transcript
DENNIS J. PURCELL has been the Senior Managing Director of Perseus-Soros BioPharmaceutical Fund, LP (PSBF), since February 2000. He is responsible for the overall …See details»
Xanodyne Pharmaceuticals, Backed by MPM Capital-led ... - Apax …
Other new investors included Perseus-Soros BioPharmaceutical Fund and affiliates of AIG Global Investment Group, while Silver Point Finance provided Xanodyne a term debt and revolver …See details»
Perseus Soros Biopharmaceutical Fund Lp Portfolio Holdings - Fintel
Perseus Soros Biopharmaceutical Fund Lp Portfolio Holdings. Insider Profile: PERSEUS SOROS BIOPHARMACEUTICAL FUND LP: Current Positions: 0: Holdings; 13D/G; Latest Holdings, …See details»
AMBIT BIOSCIENCES CORP - AMBI / Ambit Biosciences Corp / …
AMBIT BIOSCIENCES CORP - AMBI / Ambit Biosciences Corp / Perseus Soros Biopharmaceutical Fund Lp - SCHEDULE 13D Activist Investment - SC 13D - May 31, 2013.See details»
ArgiNOx Phamaceuticals - Crunchbase Company Profile & Funding
Organization. ArgiNOx Phamaceuticals . Connect to CRM . Save . Summary. Financials. People. Signals & News. About. ... ArgiNOx Phamaceuticals raised $25,000,000 / Series C from …See details»